Brain tumor vessel response to synchrotron microbeam radiation therapy: a short-term in vivo study.
The aim of this work focuses on the description of the short-term response of a 9L brain tumor model and its vasculature to microbeam radiation therapy (MRT) using magnetic resonance imaging (MRI). Rat 9L gliosarcomas implanted in nude mice brains were irradiated by MRT 13 days after tumor inoculation using two orthogonal arrays of equally spaced 28 planar microbeams (25 microm width, 211 microm spacing and dose 500 Gy). At 1, 7 and 14 days after MRT, apparent diffusion coefficient, blood volume and vessel size index were mapped by MRI. Mean survival time after tumor inoculation increased significantly between MRT-treated and untreated groups (23 and 28 days respectively, log-rank test, p < 0.0001). A significant increase of apparent diffusion coefficient was observed 24 h after MRT in irradiated tumors versus non-irradiated ones. In the untreated group, both tumor size and vessel size index increased significantly (from 7.6 +/- 2.2 to 19.2 +/- 4.0 mm(2) and +23%, respectively) between the 14th and the 21st day after tumor cell inoculation. During the same period, in the MRT-treated group, no difference in tumor size was observed. The vessel size index measured in the MRT-treated group increased significantly (+26%) between 14 and 28 days of tumor growth. We did not observe the significant difference in blood volume between the MRT-treated and untreated groups. MRT slows 9L tumor growth in a mouse brain but MRI results suggest that the increase in survival time after our MRT approach may be rather due to a cytoreduction than to early direct effects of ionizing radiation on tumor vessels. These results suggest that MRT parameters need to be optimized to further damage tumor vessels.
INSERM, U836, F38043 Grenoble, France. serduc@esrf.fr
Raphaël
R
Serduc
Thomas
T
Christen
Jean
J
Laissue
Régine
R
Farion
Audrey
A
Bouchet
Boudewijn van der
Bv
Sanden
Christoph
C
Segebarth
Elke
E
Bräuer-Krisch
Géraldine
G
Le Duc
Alberto
A
Bravin
Chantal
C
Rémy
Emmanuel L
EL
Barbier
D000818:Animals; D001932:Brain Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D018316:Gliosarcoma / Q000473:pathology / Q000532:radiotherapy*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009389:Neovascularization, Pathologic / Q000473:pathology / Q000532:radiotherapy*; D011878:Radiotherapy / Q000295:instrumentation / Q000379:methods*; D011879:Radiotherapy Dosage; D015996:Survival Rate; D017356:Synchrotrons; D013997:Time Factors; D016896:Treatment Outcome